
Fig. 1 · Downstream yield
Raises sterile-filtration step yield on rVSV
Merck and IAVI adapted the ERVEBO® purification process for an rVSVΔG-SARS-CoV-2 candidate using InVitria rHSA. Formulating the ultrafiltration product with rHSA before 0.22 µm filtration raised viral potency step yield from 42% to 74%, S protein from 27% to 59% and N protein from 41% to 72%, on equal-volume splits of the same feed.
Read the publication summary →




